Hide filtersShow filters × Close Bryan, Garnier & Co acts as Joint Global Coordinator and Joint Bookrunner on MedinCell’s Follow-on with top-tier European biotech specialists and institutional investors Bryan, Garnier & Co acts as Sole M&A and Strategic Advisor to BlueBee on its sale to Illumina Bryan, Garnier & Co acts as Sole Global Coordinator and Sole Bookrunner on Lysogene’s Private Placement with top tier US and European Investors Bryan Garnier & Co acts as Joint Bookrunner and Joint Broker to AIM-listed 4D Pharma on its GBP 22 million equity Fund Raising Bryan, Garnier & Co acts as Sole Financial Advisor to Biocodex on its Acquisition of Laboratoires IPRAD Bryan, Garnier & Co acts as Sole Bookrunner on GeNeuro EUR17.5 million Private Placement Bryan, Garnier & Co advised Lee Biosolution on its sale to Medix Biochemica Bryan, Garnier & Co acts as Sole Financial Advisor to Ingenico Group on the carve-out of its French healthcare business to Andera Partners Bryan, Garnier & Co accompanies DBV on its USD 143 million NASDAQ Follow-on Bryan, Garnier & Co acts as Joint Bookrunner to BioNTech on its USD 150 million Nasdaq Initial Public Offering Bryan, Garnier & Co acts as Joint Bookrunning Manager on Celyad’s USD 20 million global equity offering Bryan, Garnier & Co acts as Sole Financial Advisor to Inotrem on its EUR 44 million Series B Fundraising
